These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9408340)

  • 1. The effects of bisaramil and antiarrhythmics on free radical generation of isolated neutrophil granulocytes.
    Lantos J; Röth E; Paróczai M; Kárpáti E
    Acta Chir Hung; 1997; 36(1-4):186-7. PubMed ID: 9408340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisaramil and antiarrhythmics as inhibitors of free radical generation.
    Paróczai M; Röth E; Kárpáti E
    Pharmacol Res; 1997 Apr; 35(4):279-85. PubMed ID: 9264043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bisaramil on coronary-occlusion-reperfusion injury and free-radical-induced reactions.
    Paróczai M; Roth E; Matos G; Temes G; Lantos J; Karpati E
    Pharmacol Res; 1996 Jun; 33(6):327-36. PubMed ID: 8971954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotection during heart ischemia-reperfusion.
    Róth E; Lantos J; Temes G; Varga G; Paróczai M; Kárpáti E
    Acta Chir Hung; 1997; 36(1-4):306-9. PubMed ID: 9408384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade.
    Pugsley MK; Hayes ES; Saint DA; Walker MJA
    Biomed Pharmacother; 2019 Mar; 111():427-435. PubMed ID: 30594781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronotropic, inotropic, dromotropic and coronary vasodilator effects of bisaramil, a new class I antiarrhythmic drug, assessed using canine isolated, blood-perfused heart preparations.
    Haruno A; Sugiyama A; Hashimoto K
    Jpn J Pharmacol; 1999 Jul; 80(3):267-70. PubMed ID: 10461773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia.
    Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Mar; 233(1):1-6. PubMed ID: 8472737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological actions of a new antiarrhythmic drug, bisaramil, on isolated heart preparations.
    Paroczai M; Karpati E; Marko R; Kecskemeti V
    Pharmacol Res; 1992 Jan; 25(1):75-85. PubMed ID: 1738760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of cardiac Na+ channels by a charged class I antiarrhythmic agent, bisaramil: possible interaction of the drug with a pre-open closed state.
    Sunami A; Hiraoka M
    Eur J Pharmacol; 1996 Sep; 312(2):245-55. PubMed ID: 8894603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
    Haruno A; Hashimoto K
    Jpn J Pharmacol; 1995 May; 68(1):95-102. PubMed ID: 7494388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the beta-blocker therapy on neutrophil superoxide generation and platelet aggregation in experimental myocardial ischemia and reflow.
    Röth E; Matos G; Guarnieri C; Papp B; Varga J
    Acta Physiol Hung; 1995; 83(2):163-70. PubMed ID: 8588503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations to characterize a new antiarrhythmic drug bisaramil.
    Paroczai M; Karpati E
    Pharmacol Res; 1991 Aug; 24(2):149-62. PubMed ID: 1684242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels.
    Pugsley MK; Goldin AL
    Eur J Pharmacol; 1998 Jan; 342(1):93-104. PubMed ID: 9544797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil.
    Pieper GM; Gross GJ
    Cardiovasc Drugs Ther; 1992 Jun; 6(3):225-32. PubMed ID: 1322163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro modulation of human neutrophil superoxide anion generation by various calcium channel antagonists used in ischemia-reperfusion resuscitation.
    Zimmerman JJ; Zuk SM; Millard JR
    Biochem Pharmacol; 1989 Oct; 38(20):3601-10. PubMed ID: 2554927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selected antiarrhythmic drugs on the superoxide anion production by polymorphonuclear neutrophils in vitro.
    Wysocka E; Wysocki H; Siminiak T; Szczepanik A
    Cardiology; 1989; 76(4):264-9. PubMed ID: 2553259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of lidocaine on oxygen free radical production by polymorphonuclear neutrophils.
    Siminiak T; Wysocki H
    Agents Actions; 1992; Spec No():C104-5. PubMed ID: 1332451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of bisaramil on experimental arrhythmias.
    Paróczai M; Kárpáti E; Solti F
    Pharmacol Res; 1990; 22(4):463-80. PubMed ID: 2402479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of selected antiarrhythmic drugs on neutrophil free oxygen radicals production measured by chemiluminescence.
    Siminiak T; Wysocki H; Veit A; Maurer HR
    Basic Res Cardiol; 1991; 86(4):355-62. PubMed ID: 1958173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by nilvadipine of ischemic and carrageenan paw edema as well as of superoxide radical production from neutrophils and xanthine oxidase.
    Oyanagui Y; Sato S
    Arzneimittelforschung; 1991 May; 41(5):469-74. PubMed ID: 1654907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.